These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 500327)

  • 1. Crystallization studies in a urothelial-lined living test tube (the catheterized female rat bladder). I. Calcium oxalate crystal adhesion to the chemically injured rat bladder.
    Gill WB; Ruggiero K; Straus FH
    Invest Urol; 1979 Nov; 17(3):257-61. PubMed ID: 500327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of the metastable limits and absence of container surface nucleation for calcium oxalate crystallization in a urothelial-lined system as compared to glass containers.
    Gill WB; Ruggiero KJ; Fromes MC
    Invest Urol; 1980 Sep; 18(2):158-61. PubMed ID: 7410029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature.
    Khan SR; Hackett RL
    Scan Electron Microsc; 1985; (Pt 2):759-74. PubMed ID: 3901237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal retention by injured urothelium of the rat urinary bladder.
    Khan SR; Cockrell CA; Finlayson B; Hackett RL
    J Urol; 1984 Jul; 132(1):153-7. PubMed ID: 6726949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [14C-oxalate autoradiographic studies on distribution of oxalate and calcium oxalate crystal fixation in rat kidney].
    Ishii K; Sugimoto T; Kamikawa S; Kanazawa T; Nakatani T; Yamamoto K; Kishimoto T; Funae Y
    Hinyokika Kiyo; 1998 Apr; 44(4):245-51. PubMed ID: 9617620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of calcium oxalate crystals on urothelium: effect of free radicals.
    Grases F; García-Ferragut L; Costa-Bauzá A
    Nephron; 1998; 78(3):296-301. PubMed ID: 9546690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effect of oral administration of Takusya on calcium oxalate crystallization in human whole urine].
    Honda M; Yoshimura K; Miyake O; Yoshioka T; Okuyama A; Yamaguchi S; Utsunomiya M; Koide T; Sugiyama K
    Hinyokika Kiyo; 1997 May; 43(5):333-7. PubMed ID: 9208316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
    Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid as inducer of calcium oxalate crystal development.
    Grases F; Sanchis P; Isern B; Perelló J; Costa-Bauzá A
    Scand J Urol Nephrol; 2007; 41(1):26-31. PubMed ID: 17366099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell.
    Yamate T; Kohri K; Umekawa T; Iguchi M; Kurita T
    J Urol; 1998 Oct; 160(4):1506-12. PubMed ID: 9751404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals.
    Farell G; Huang E; Kim SY; Horstkorte R; Lieske JC
    J Am Soc Nephrol; 2004 Dec; 15(12):3052-62. PubMed ID: 15579508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.